Carlos EduardoPoli De Figueiredo Brazil

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Innovations in Transplantation Gervasio Soler-Pujol Chairperson gsolerpujol@gmail.comMD MarioSchiffer Chairperson mario.schiffer@uk-erlangen.deUniversity hospital ErlangenGermany Update in Robotic Kidney Transplantation RajeshSivaprakasam Speaker United Kingdom Progress in Xenotransplantation MeganSykes Speaker ms3976@cumc.columbia.eduUnited States Antigen-specific Chimeric Antigen Receptor Regulatory T Cells for Use in Solid Organ Transplantation CarolineLamarche Speaker caroline.lamarche.1@umontreal.caUniversité de MontréalCanada Post Transplant TMA-pathogenesis and Management LilianMonteiro P. Palma Speaker lilian.palma@icloud.comState University of CampinasBrazil Q and A Hall A
10:30 a.m. 11 a.m.	Hitting the Four Hits: The Potential of Dual BAFF/APRIL Inhibition in IgA Nephropathy JonathanBarratt Spotlight Speaker University of Leicester, Leicester, UKUnited Kingdom Spotlight Stage 1 (exhibition hall)
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) AgnesFogo Chairperson United States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria Hall A
12:15 p.m. 1:15 p.m.	Strategies to Reduce Inequity of PD Provision Globally: ISN-ISPD Joint Session AdrianLiew Chairperson Mount Elizabeth Novena Hospital, SingaporeSingapore DanielaPonce Chairperson daniela.ponce@unesp.brBotucatu School of Medicine - University of Sao Paulo StateBrazil Growing PD Globally: Outcomes From the International Home Dialysis Consortium EdwinaBrown Speaker Imperial College Healthcare NHS TrustUnited Kingdom Overcoming Barriers to PD in Low-middle Income Countries Magdalena Madero Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico Public Policy and Home Dialysis Utilization: High-income Country Perspective RajnishMehrotra Speaker University of WashingtonUnited States Debate Hall C4			Onconephrology: Various Flavors of AKI JavierDe Arteaga Chairperson javierdearteaga@gmail.comHospital Privado Universitario de Cordoba. Catholic University from CordobaArgentina KarinaSoto Chairperson Centro Hospitalar de Setubal, EPE and CEDOC Universidade Nova de LisboaPortugal SandraHerrmann Chairperson herrmann.sandra@mayo.eduMayo ClinicUnited States AKI-related Cancer and Cancer Treatment-related TMA ClaraGarcía Carro Speaker claragarciacarro@hotmail.comSan Carlos Clinical Hospital (Madrid, Spain)Spain AKI Related to Cancer Immunotherapy: Can Biomarkers Help? SebastianLapman Speaker lapseba@yahoo.com.arArgentina Magnesium and AKI: Is There a Connection? From Bench to Bedside - What We Can Learn from Onconephrology JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland Q and A Hall E
1 p.m. 1:45 p.m.	Kidney Tank: Social Media as a Professional Tool MythriShankar Spotlight Speaker Institute of NephrourologyIndia Augusto CesarSoares dos Santos Junior Spotlight Chairperson Hospital das Clinicas, UFMG; Fac Ciências MedicasBrazil FernandaArce Spotlight Chairperson Mexico RolandoClaure Del Granado Spotlight Speaker Division of Nephrology, Hospital Obrero No 2 - Caja Nacional de Salud, Cochabamba Bolivia Spotlight Stage 2
3 p.m. 4 p.m.	A Balancing Act: Your Kidneys and Electrolytes Angela Yee-MoonWang Chairperson Hong Kong/SingaporeSingapore ThiagoDe Azevedo Reis Chairperson thiagoreisnefro@gmail.comHospital Sírio-Libanês, São Paulo, Brazil & Fenix Brazil Is Magnesium a Missing Puzzle for Vascular Calcification in CKD? SolaAoun Bahous Speaker sola.bahous@gmail.comLebanese American University School of MedicineLebanon Should Potassium Be Restricted or Not in CKD? RobertoPecoits Filho Speaker Arbor Research Collaborative for HealthUnited States Metabolic Acidosis in CKD: When to Treat? What to Target? MitchellRosner Speaker Univeristy of Virginia HealthUnited States Q and A Hall A		Kidney Health for All - Advancing Equitable Access to Care and Optimal Medication Practice: WKD Session DinaAbdellatif Chairperson Cairo University HospitalEgypt VassiliosLiakopoulos Chairperson liakopul@otenet.gr2nd Department of Nephrology, AHEPA Hospital, Medical School, Aristotle University of Thesalloniki, GreeceGreece Building Bridges to Reduce Fragmentation of Kidney Care RicardoCorrea Rotter Speaker correarotter@gmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico Transforming Kidney Care Through Equitable Breakthrough Therapies KatherineTuttle Speaker University of Washington School of Medicine, Division of NephrologyUnited States Closing the Gaps: Implementing Best Practices for CKD Care Worldwide ValerieLuyckx Speaker valerie.luyckx@uzh.chUniversity of ZurichSwitzerland A Patient's Perspective on Gaps in Care MariaSeijas Speaker Mseijas@ifc.orgCFAArgentina Q and A Hall C1		Cardiorenal Syndrome: Updates in the Pathophysiology and State-of-the-Art Treatment FelipeInserra Chairperson felipe.inserra@gmail.comArgentina YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States New Insights into the Mechanisms of Kidney Injury in the CRS WendyMccallum Speaker wmccallum@tuftsmedicalcenter.orgUnited States Novel Pharmacological Treatments of the CRS MarkSarnak Speaker msarnak@tuftsmedicalcenter.orgTufts Medical CenterUnited States Device-related Treatment for CRS ClaudioRonco Speaker cronco@goldnet.itInternational Renal Research Institute of VicenzaItaly Q and A Hall D
4 p.m. 4:30 p.m.	Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis BradRovin Spotlight Speaker The Ohio State UniversityUnited States UptalPatel Spotlight Speaker United States Spotlight Stage 1 (exhibition hall)
4:30 p.m. 5:30 p.m.	New Developments in CKD Epidemiology Research MaartenTaal Chairperson University of NottinghamUnited Kingdom RobertoPecoits Filho Chairperson Arbor Research Collaborative for HealthUnited States Big Data Lab Patient-reported Outcome Measures: How Do Patients Experience CKD? AdeeraLevin Speaker University of British Columbia and Providence Health CareCanada Trial Simulation Using Observational Data AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgArbor Research Collaborative for HealthUnited States Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges DorotheaNitsch Speaker London School of Hygiene & Tropical MedicineUnited Kingdom Q and A Hall C4
5:30 p.m. 6 p.m.	Challenges pertaining to peritoneal dialysis practice in Latin America: a dialogue between nurses and doctors Spotlight Stage 2

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	ADPKD Updates CarlosDiaz Chairperson cdiaz@cemic.edu.arSección Nefrología, Departamento de Medicina Interna, Instituto Universitario CEMIC.Argentina CristianKramer Chairperson cristiankramer@yahoo.eshosptial ramos mejìaArgentina Role of Genetic Testing in ADPKD PeterHarris Speaker harris.peter@mayo.eduMayo ClinicUnited States New Metabolic Pathways Driving PKD Progression AlessandraBoletta Speaker boletta.alessandra@hsr.itSan Raffaele Scientific InstituteItaly ADPKD Management Guidelines AlfredoWassermann Speaker awasser@gmail.comFEPREVAArgentina The Future Landscape for ADPKD Treatment VicenteTorres Speaker Mayo ClinicUnited States Q and A Hall C1		Insights From Understanding Heterogeneous Trajectories to Kidney Failure FacundoDaminato Chairperson fmdaminato@hotmail.comArgentina Magdalena Madero Chairperson Chief of Nephrology, Instituto Nacional de CardiolMexico PietroRavani Chairperson pravani@ucalgary.caUniversity of CalgaryCanada Non-neoplastic Lesions in Nephrectomy Samples: Implications for Kidney Function JairMunoz Mendoza Speaker JMMendoza@med.miami.eduUniversity of MiamiUnited States Understanding the Heterogeneous Trajectory of CKD MorganGrams Speaker morgan.grams@nyulangone.orgNew York UniversityUnited States Review of Medical Therapies Proven to Delay CKD Progression DoreenZhu Speaker doreen.zhu@ndph.ox.ac.ukUniversity of OxfordUnited Kingdom Impact of Obesity and Novel Treatment Strategies on CKD Progression PeterRossing Speaker Steno Diabetes Center Copenhagen Denmark Q and A Hall C4		Hypertension - the Cutting Edge: Advances in Science and Management TaraChang Chairperson tichang@stanford.eduStanford UniversityUnited States Veronica Ferraris Chairperson veronica.ferraris@hospitalitaliano.org.arServicio de Nefrología Pediátrica. Hospital Italiano de Buenos Aires. (Argentina) Behind the Numbers: Exploring the Molecular Mechanisms of Hypertension GerardoGamba Speaker gamba@biomedicas.unam.mxUniversidad Nacional Autónoma de MéxicoMexico Hypertension - the Cutting Edge: Is It Time for Sex-specific Management of Hypertension? TaliElfassy Speaker t.elfassy@med.miami.eduUnited States State-of-the-Art Treatment of Hypertension in Pediatrics With CKD RahulChanchlani Speaker chanchlr@mcmaster.caMcMaster Children's Hospital, Hamilton, CanadaCanada State-of-the-Art Treatment of Hypertension in Adults With CKD SusanneNicholas Speaker sunicholas@mednet.ucla.eduDavid Geffen School of Medicine at UCLAUnited States Q and A Hall D
11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala MegJardine Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Generative AI Revolution in Medicine MichalRosen-Zvi Speaker ROSEN@il.ibm.comhttps://research.ibm.com/Israel Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh Hall A
12 p.m. 1 p.m.	Chronic Kidney Disease and the Global Public Health Agenda MonicaWang Spotlight Speaker monica.wang@nature.comNature Reviews of NephrologyUnited Kingdom VivekanandJha Spotlight Speaker George Institute for Global Health IndiaIndia Spotlight Stage 1 (exhibition hall)
12:15 p.m. 1:15 p.m.	The Journey of a Patient with Kidney and Cardiovascular Diseases: From Detection to Referral to Co-management RobertoPecoits Filho Chairperson Arbor Research Collaborative for HealthUnited States Challenges in the Early Detection and Management of a Patient at the Interface of Kidney and Heart Disease MarisolTorres Toledano Speaker torres.t.marisol@gmail.comIMSS, MEXICO Mexico Co-management of Patients With Cardio-Kidney Diseases: Let DebasishBanerjee Speaker St George's University Hospital NHS Foundation TrUnited Kingdom Co-management of Patients With Cardio-Kidney Diseases: Let CharlesHerzog Speaker Charles.Herzog@cdrg.orgISN and Hennepin Healthcare/University of MinnesUnited States Q and A Hall C1
12:45 p.m. 1:30 p.m.	Keys to success to be on top of what is published in nephrology (ISN-ACT) AndreaViecelli Spotlight Speaker University of QueenslandAustralia Augusto CesarSoares dos Santos Junior Spotlight Speaker Hospital das Clinicas, UFMG; Fac Ciências MedicasBrazil BrendanSmyth Spotlight Speaker brendan.smyth@sydney.edu.auAustralia DavidWheeler Spotlight Speaker University College LondonUnited Kingdom MegJardine Spotlight Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Spotlight Stage 1 (exhibition hall)
2:45 p.m. 3:15 p.m.	What nephrologists can learn from nurses Laura Lunardi Speaker laura.lunardi@sa.gov.auAustralia Ana Elizabeth pradofigueiredo Spotlight Speaker Pontifícia Universidade Católica do Rio Grande do Brazil HelenHurst Spotlight Speaker h.e.hurst@salford.ac.ukUniversity of Salford and Northern Care Alliance NUnited Kingdom RachaelWalker Spotlight Chairperson University of Auckland, New ZealandNew Zealand Spotlight Stage 1 (exhibition hall)
3 p.m. 4 p.m.	Late Breaking Clinical Trials Session AlessiaFornoni Chairperson University of Miami United States MichelleRheault Chairperson rheau002@umn.eduUniversity of MinnesotaUnited States Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict) PietroRavani Free Communication pravani@ucalgary.caUniversity of CalgaryCanada Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas Wladimir MietekSzpirt Speaker wladimir.mietek.szpirt.01@regionh.dkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research ConsultantDenmark EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY DanaRizk Free Communication drizk@uabmc.eduUniversity of Alabama at BirminghamUnited States SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL JonathanBarratt Free Communication University of Leicester, Leicester, UKUnited Kingdom PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT CécileCouchoud Free Communication cecile.couchoud@biomedecine.frREIN registry, Agence de la biomédecine, FranceFrance Hall A			Professor Donal O'Donoghue Global Kidney Policy Forum: Introduction and Scene Setting IfeomaUlasi Chairperson College of Medicine, University of NigeriaNigeria Nelson AlbertoCastro Moderator trischt19@gmail.comArgentina Welcome to The Donal O MasaomiNangaku Speaker Japan Welcome to Argentina and the Local Context Leonardo OscarBusso Speaker audiencias@msal.gov.arMinisterio de Salud de la Nación - Republica ArgentinaArgentina The Donal O IfeomaUlasi Speaker College of Medicine, University of NigeriaNigeria PAHO Perspective AnselmHennis Speaker hennisa@paho.orgPAHO/WHOUnited States 2023 ISN-GKHA Regional Paper Perspective CarmenTzanno Branco Martins Speaker SLANH, ISNBrazil Patient Representative's Insights on the Importance of Accessibility in Kidney Health MarianellaSierra Canales Speaker presidenciaclaycop@gmail.comISN, Consejo Latinoamericano y del caribe de Pacientes trasplantados y en situación de trasplante (CLAYCOP)/FUNLUVI-HONDURASHonduras Q and A Hall C2
3:50 p.m. 5:40 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Advancing Accessibility in Kidney Health - Towards Sustainable Solutions IfeomaUlasi Chairperson College of Medicine, University of NigeriaNigeria Nelson AlbertoCastro Moderator trischt19@gmail.comArgentina Accessibility to CKD Diagnosis: Focus on CKDu (Chronic Kidney Disease of Unknown Origin) and Advancements in Diagnostic Approaches RamonGarcia Trabanino Speaker rgtrab@gmail.comSLANHEl Salvador Latin American Dialysis and Renal Transplantation Registry: Updates and Progress MariaGonzalez Speaker registro@slanh.netSLANHUruguay Special Situations in Argentina: Addressing the Challenges Faced by Individuals on Dialysis Without a Diagnosis in the Argentinian Registry GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina Cardiovascular and Renal Risk Factors in Argentinian First Nations: A Study of Qom and Wichi Indigenous Groups Maria Eugenia VictoriaBianchi Speaker bianchimaria@me.comISN. SAN.Argentina Accessibility to Substitution Treatment in Latin America AlejandroFerreiro-Fuentes Speaker Centro de Nefrología. Universidad de la República,Uruguay Accessibility to Programs of Prevention, and Early Detection and Treatment of Kidney Disease in Latin America Alfonso MartinCueto Manzano Speaker a_cueto_manzano@hotmail.comUnidad de Investigación Médica en Enfermedades RenMexico Break Panel Discussion and Closing Remarks by Valerie Luyckx, University of Zurich, Switzerland Hall C2
4:30 p.m. 5:30 p.m.	Paraproteinemia and the Kidney CarolineLamarche Chairperson caroline.lamarche.1@umontreal.caUniversité de MontréalCanada Gustavo CristianGreloni Chairperson gustavo.greloni@hospitalitaliano.org.arArgentina MGRS: Should All Forms Need Clonal Therapy? FrankBridoux Speaker f.bridoux@chu-poitiers.frDepartment of Nephrology and French Reference Center for AL amyloidosis and MGRS, University Hospital, Poitiers, FranceFrance Renal Amyloidosis: What Is New? Veronica Torres CostaSilva Speaker veronica.torres@hc.fm.usp.brSão Paulo State Cancer Institute - University of São PauloBrazil Can We Perform a Transplant in Patients with Myeloma and Amyloidosis? SabineKaram Speaker University of MinnesotaUnited States Q and A Hall A

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10 a.m.	Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment DebasishBanerjee Chairperson St George's University Hospital NHS Foundation TrUnited Kingdom MegJardine Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Setting the Scene MegJardine Speaker NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia DM and CKD: Which Treatment Should I Use for Different Populations? KatherineTuttle Speaker University of Washington School of Medicine, Division of NephrologyUnited States How to Design Studies on Answering Unanswered Questions VladoPerkovic Speaker University of New South Wales, Sydney, AustraliaAustralia The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes DavidWheeler Speaker University College LondonUnited Kingdom Q and A Hall C4	Hi Aldo, What's New? Advances in Aldosterone in Health and Disease CarlosSchreck Chairperson carlos.schreck@gmail.comHospital Italiano de Buenos Aires- NephrologyArgentina KellyHaughton Chairperson kidneydoctorpanama@gmail.comSLANH, PanamaPanama Why Are Fewer Than I% Of Hypertensive Patients Ever Screened For Primary Aldosteronism? John Funder Speaker John.Funder@hudson.org.auThe Hudson Institute of Medical Research Clayton 3168 Victoria Australia; Monash University, Clayton 3600 Victoria AustraliaAustralia Aldosterone and Disease JordanaCohen Speaker jco@pennmedicine.upenn.eduUniversity of PennsylvaniaUnited States New Trials Using Aldosterone Synthese Blockade MichelAzizi Speaker michel.azizi@aphp.frUniversité Paris Cité, Hypertension department, HôFrance Targeting MR for Heart and Kidney Protection HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall E
9 a.m. 10:30 a.m.	Clinical Management of Glomerulonephritis (GN) Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico ValeriaAlberton Chairperson vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina Updates on IgAN Management HernánTrimarchi Speaker HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina Membranous GN Classification and Management PierreRonco Speaker Hôpital TenonFrance MPGN Updates SanjeevSethi Speaker Mayo ClinicUnited States Managing Vasculitis RobertaFenoglio Speaker roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly Q and A Hall A
11 a.m. 12:15 p.m.	Plenary Session 4: Insights into SGLT2 Inhibitors: A Story of Discovery (Ele Ferrannini, Italy) AlessiaFornoni Chairperson University of Miami United States LizLightstone Chairperson Imperial College LondonUnited Kingdom MasaomiNangaku Chairperson Japan Acceptance Speech: Bywaters Award MotokoYanagita Speaker Kyoto UniversityJapan Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture EleFerrannini Speaker eleferrannini@gmail.comUniversity of PisaItaly ELP2 Graduation MasaomiNangaku Speaker Japan Hall A
12:30 p.m. 1:30 p.m.	Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? MarceloOrías Chairperson marcelo.orias@gmail.comArgentina MarkSarnak Chairperson msarnak@tuftsmedicalcenter.orgTufts Medical CenterUnited States Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - PROS TaraChang Speaker tichang@stanford.eduStanford UniversityUnited States Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - CONS JordanaCohen Speaker jco@pennmedicine.upenn.eduUniversity of PennsylvaniaUnited States Hall A	New Insights into C3 Glomerulonephritis: Focus on Pathogenesis and Potential Therapeutic Targets AnujaJava Chairperson WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUISUnited States LizLightstone Chairperson Imperial College LondonUnited Kingdom Complement in Kidney Disease: Overview of the Complement Cascade in Kidney Injury Peter Zipfel Speaker Peter.Zipfel@hki-jena.deLeibniz Institute for Natural Product Research and Infection BiologyGermany C3 Glomerulopathy: New Developments and Therapeutic Targets CarlaNester Speaker carla-nester@uiowa.eduUniversity of IowaUnited States Challenges in Diagnosing C3G SallyJohnson Speaker sallyajohnson73@gmail.comNational Renal Complement Therapeutics Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, United KingdomUnited Kingdom Q and A Hall C1

Pre-Congress - Saturday April 13, 2024

Time	Session

9 a.m. 11 a.m.	Renal Pathology Course: New Insights in Glomerular Disease: Part 1 CarmenAvila Casado Chairperson University of Toronto, UHNCanada ValeriaAlberton Chairperson vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina WesamIsmail Chairperson wesam_ismail@yahoo.comHead of Pathology Department, Beni Suef UniversityEgypt Updates in Genetic Testing in Renal Disease DanicaGalešić Ljubanović Speaker danica.ljubanovic@mef.hrUniversity of Zagreb, School of Medicine, Department of Pathology and Dubrava University Hospital, Zagreb, CroatiaCroatia Classification of Lupus AgnesFogo Speaker United States New Insights in Membranous Nephropathy SanjeevSethi Speaker Mayo ClinicUnited States Amyloidosis Update WesamIsmail Speaker wesam_ismail@yahoo.comHead of Pathology Department, Beni Suef UniversityEgypt Q and A Hall C1	Navigating Kidney Care Symposium: From Guidelines to Practice, Personalized Care, and Quality of Life: PD: Translating Guidelines to Clinical Practice Ana Elizabeth pradofigueiredo Chairperson Pontifícia Universidade Católica do Rio Grande do Brazil ReenaGeorge Chairperson Christian Medical College Vellore, Tamil Nadu, IndiaIndia How to Provide High Quality PD as a Viable Option for Low Resource Settings: The Autonomous Role of Nurses MarthaDevia Speaker martha.e.devia@gmail.comISN, ACOENEColombia Training and Re-training, Whats Is New? ReenaGeorge Speaker Christian Medical College Vellore, Tamil Nadu, IndiaIndia PD Catheter Related Infections: How to Integrate Research into Clinical Practice Ana Elizabeth pradofigueiredo Speaker Pontifícia Universidade Católica do Rio Grande do Brazil Discussion Hall C3
11:30 a.m. 1:30 p.m.	Renal Pathology Course: New Insights in Glomerular Disease: Part 2 CarmenAvila Casado Chairperson University of Toronto, UHNCanada ValeriaAlberton Chairperson vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina WesamIsmail Chairperson wesam_ismail@yahoo.comHead of Pathology Department, Beni Suef UniversityEgypt Podocytopathies CarmenAvila Casado Speaker University of Toronto, UHNCanada Implementation of Electronic Microscopy. How to Handle Renal Biopsies Maria FernandaToniolo Speaker mftoniolo@hotmail.comArgentina Diabetic Nephropathy ValeriaAlberton Speaker vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina Updates in Consensus in Anti-phospholipid Antibodies SuryaSeshan Speaker Weill Cornell MedicineUnited States Q and A Hall C1	Navigating Kidney Care Symposium: From Guidelines to Practice, Personalized Care, and Quality of Life: HD: Individualized Care Ana Elizabeth pradofigueiredo Chairperson Pontifícia Universidade Católica do Rio Grande do Brazil ReenaGeorge Chairperson Christian Medical College Vellore, Tamil Nadu, IndiaIndia Volume Management: Individualizing Care Wilmer JimEscobar Torres Speaker jimccv@gmail.comWilmer Jim Escobar TorresPeru Potassium is Not the Villain Rafaela Siviero Caron-Lienert Speaker rafaelacaronlienert@gmail.comPUCRSBrazil Assessment and Management of AV Access: Case Management ClementeSousa Speaker clementesousa@esenf.ptEscola Enfermagem PortoPortugal Discussion Hall C3
2:15 p.m. 4:15 p.m.	Renal Pathology Course - Clinicopathological Correlations. With support from GlomCon CarmenAvila Casado Chairperson University of Toronto, UHNCanada ValeriaAlberton Chairperson vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina WesamIsmail Chairperson wesam_ismail@yahoo.comHead of Pathology Department, Beni Suef UniversityEgypt Nephrologist, Clinical Discussant - Case 1 JoselynReyes Bahamonde Speaker jopy32@gmail.comClinical Assistant Professor United States Case 1 EmiliaGarcia Chiple Speaker emiliachiple@gmail.comArgentine Society of Pathology (SAP) / InternationArgentina Nephrologist, Clinical Discussant - Case 2 JoselynReyes Bahamonde Speaker jopy32@gmail.comClinical Assistant Professor United States Case 2 SuryaSeshan Speaker Weill Cornell MedicineUnited States Nephrologist, Clinical Discussant - Case 3 JoselynReyes Bahamonde Speaker jopy32@gmail.comClinical Assistant Professor United States Case 3 LuizMoura Speaker morphos@dialdata.com.brAssociate professor, Nephrology DivisionBrazil Nephrologist, Clinical Discussant - Case 4 JoselynReyes Bahamonde Speaker jopy32@gmail.comClinical Assistant Professor United States Case 4 JorisRoelofs Speaker Amsterdam UMCNetherlands Nephrologist, Clinical Discussant - Case 5 JoselynReyes Bahamonde Speaker jopy32@gmail.comClinical Assistant Professor United States Case 5 GeetikaSingh Speaker All India Institute of Medical Sciences, New Delhi, India India Nephrologist, Clinical Discussant - Case 6 JoselynReyes Bahamonde Speaker jopy32@gmail.comClinical Assistant Professor United States Case 6 TurkiAl-Hussain Speaker turkihussain@kfshrc.edu.saKing Faisal Specialist Hospital and Research CentrSaudi Arabia Hall C1	Navigating Kidney Care Symposium: From Guidelines to Practice, Personalized Care, and Quality of Life: Enhancing Patient Quality of Life Ana Elizabeth pradofigueiredo Chairperson Pontifícia Universidade Católica do Rio Grande do Brazil ReenaGeorge Chairperson Christian Medical College Vellore, Tamil Nadu, IndiaIndia Mental Health and Wellbeing in Dialysis Patients RachaelWalker Speaker University of Auckland, New ZealandNew Zealand Laughter Therapy to Promote Physical Activity and Exercise in People with Kidney Failure PaulBennett Speaker paul.bennett@griffith.edu.auGriffith UniversityAustralia End of Life Care Planning: Supporting Families and Patients HelenHurst Speaker h.e.hurst@salford.ac.ukUniversity of Salford and Northern Care Alliance NUnited Kingdom Discussion Hall C3
2:45 p.m. 4:05 p.m.	Sharing Expertise to Support the Set-up of Renal Registries: The Global Situation and Inspiration from Established Registries in Latin America: Part 2 FergusCaskey Chairperson University of Bristol, UKUnited Kingdom MariaPippias Chairperson University of BristolUnited Kingdom The Uruguayan Renal Registry LeonellaLuzardo Speaker leonellaluzardo@gmail.comNephrology Center Hospital de ClínicasUruguay The Columbian Renal Registry CarlosMejia Speaker mejia.carlos@correoinivalle.edu.coColombia The Costa Rican Renal Registry GuillermoRodriguez Speaker guillermorzmz@gmail.comCosta Rica Panel Discussion with Speakers How To Get Involved In SharE-RR MariaPippias Speaker University of BristolUnited Kingdom Closing and Final Remarks FergusCaskey Speaker University of Bristol, UKUnited Kingdom Sala 1
4:30 p.m. 6 p.m.	WCN'24 Opening Ceremony and Plenary Session 1: The Origin of the Universe (Daniel de Florian, Argentina) ISN President's Address MasaomiNangaku Speaker Japan Tribute to Stewart Cameron Welcome by WHO Director of Non-Communicable Diseases Dr Bente Mikkelsen Welcome by Dr. Marina Papaginovic, SAN President; Dr. Guillermo Rosa Diez, WCN Local Organising Group Chair; and Dr. Jorge Rico, SLANH President and WCN Local Organizing Group co-Chair GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina JorgeRico Speaker jorgericof@yahoo.comColombia MariaPapaginovic Leiva Speaker drapapaginovicleiva@gmail.comArgentina Welcome by Minister of Health for Buenos Aries Dr Fern Welcome by SPWG Chair Alessia Fornoni AlessiaFornoni Speaker University of Miami United States The Origin of the Universe DanielDe Florian Speaker deflo@unsam.edu.arUniversidad Nacional de San MartinArgentina Acceptance Speech: Hamburger Award AdeeraLevin Speaker University of British Columbia and Providence Health CareCanada Hall A